ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 248 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2022. The put-call ratio across all filers is 52.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,606,257 | -40.0% | 122,242 | -42.4% | 0.00% | -40.0% |
| Q2 2023 | $2,676,289 | -30.5% | 212,404 | -28.0% | 0.01% | -37.5% |
| Q1 2023 | $3,848,455 | -24.2% | 294,901 | +2.5% | 0.01% | -20.0% |
| Q4 2022 | $5,074,320 | +22.5% | 287,660 | +5.7% | 0.01% | +11.1% |
| Q3 2022 | $4,142,000 | +71.5% | 272,200 | +67.1% | 0.01% | +80.0% |
| Q2 2022 | $2,415,000 | -41.4% | 162,902 | -11.1% | 0.01% | -28.6% |
| Q1 2022 | $4,123,000 | +4.1% | 183,164 | -14.7% | 0.01% | +16.7% |
| Q4 2021 | $3,959,000 | -3.7% | 214,669 | -30.2% | 0.01% | -14.3% |
| Q3 2021 | $4,109,000 | -44.4% | 307,468 | -23.0% | 0.01% | -41.7% |
| Q2 2021 | $7,390,000 | +44.1% | 399,306 | +16.8% | 0.01% | +33.3% |
| Q1 2021 | $5,129,000 | -36.9% | 341,760 | -39.3% | 0.01% | -43.8% |
| Q4 2020 | $8,122,000 | +70.9% | 562,795 | -3.7% | 0.02% | +60.0% |
| Q3 2020 | $4,753,000 | +14.3% | 584,261 | -4.9% | 0.01% | +11.1% |
| Q2 2020 | $4,157,000 | -10.9% | 614,640 | -7.3% | 0.01% | -25.0% |
| Q1 2020 | $4,668,000 | -66.0% | 663,105 | -52.5% | 0.01% | -53.8% |
| Q4 2019 | $13,714,000 | +15.5% | 1,397,156 | +28.8% | 0.03% | +13.0% |
| Q3 2019 | $11,872,000 | -5.5% | 1,084,615 | +0.3% | 0.02% | 0.0% |
| Q2 2019 | $12,561,000 | +4.5% | 1,081,639 | -14.1% | 0.02% | +4.5% |
| Q1 2019 | $12,015,000 | +0.1% | 1,258,550 | +1.0% | 0.02% | -18.5% |
| Q4 2018 | $12,001,000 | -37.7% | 1,246,111 | -7.8% | 0.03% | -25.0% |
| Q3 2018 | $19,252,000 | +22.7% | 1,351,204 | +3.4% | 0.04% | +9.1% |
| Q2 2018 | $15,687,000 | -0.1% | 1,307,045 | +2.8% | 0.03% | +22.2% |
| Q1 2018 | $15,698,000 | -24.3% | 1,271,159 | -10.7% | 0.03% | -22.9% |
| Q4 2017 | $20,739,000 | +21.9% | 1,423,440 | +19.0% | 0.04% | +20.7% |
| Q3 2017 | $17,020,000 | +50.4% | 1,196,071 | +34.9% | 0.03% | +45.0% |
| Q2 2017 | $11,315,000 | +75.0% | 886,734 | +73.9% | 0.02% | +66.7% |
| Q1 2017 | $6,467,000 | -9.9% | 510,025 | -26.0% | 0.01% | -14.3% |
| Q4 2016 | $7,178,000 | – | 689,572 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
| EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
| Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
| KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
| Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
| Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
| PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |